PET Imaging of 68Ga-NOTA-H006 in Malignancy

Inclusion criteria

• Pancreatic cancer clinical trial study subjects must meet all of the following criteria:

• Age between 18 and 65 years old.
• Pancreatic occupancy is found on imaging and combined with clinical judgment as a patient with pancreatic cancer.
• Written informed consent signed by the subject or his/her legal guardian or caregiver.
• Willingness and ability to cooperate with all programs of the study.

Lung cancer clinical trial study subjects must meet all of the following criteria:

• Be between the ages of 18 and 65 years old.
• Patients with CT findings of suspicious space on the lungs with a diameter of more than 1cm who have not undergone surgery.
• Written informed consent must be signed by the subject or his/her legal guardian or caregiver.
• Willingness and ability to cooperate with all programs of the study.

Bowel cancer clinical trial study subjects must meet all of the following criteria:

• Be between the ages of 18 and 65.
• Have a clear histologic or pathologic diagnosis of colorectal cancer.
• Written informed consent signed by the subject or legal guardian or caregiver.
• Willingness and ability to cooperate with all programs of this study.

Exclusion criteria

• Severe hepatic or renal insufficiency;
• Targeted therapy prior to radiotherapy or PET/CT scan. 5T4 expression in existing lesions assessed by immunohistochemistry using antibody clones.
• History of serious surgery in the last month.
• Those who have participated in other clinical trials during the same period.